EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis

Sandra Smieszek, Bartlomiej Przychodzen, Christina Tyner, Caroline Johnson, Margaret Bushman, Jennifer Brzezynski, Adam Reich, Hervé Bachelez, Evelyn Wen Yee Yap, Murat Borlu, Suteeraporn Chaowattanapanit, Mohamed Denguezli und 12 weitere

NEJM Evidence · 2026

DOI: 10.1056/evidoa2500272 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, 2026. Verfasst von Sandra Smieszek und 23 weiteren Autor:innen. Beteiligte Einrichtung: Vanda Pharmaceuticals Inc., Washington, DC, USA. Hauptthemen laut MEDLINE: Psoriasis, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisAntibodies, Monoclonal, HumanizedAntibodies, MonoclonalHumansFemaleMaleDouble-Blind MethodMiddle AgedAdultAdolescentAgedAged, 80 and overTreatment OutcomeYoung Adult

Substanzen

Antibodies, Monoclonal, HumanizedAntibodies, Monoclonal

Autor:innen und Institutionen

  • Vanda Pharmaceuticals Inc., Washington, DC, USA.
  • University of Rzeszów, Rzeszów, Poland.
  • Saint-Louis APHP Hospital, Université Paris Cité, Paris, France.
  • Hospital Pakar Sultanah Fatimah Muar, Johor, Malaysia.
  • Eciyes University, Kayseri, Turkey.
  • Srinagarind Hospital, Khon Kaen, Thailand.

Zitieren

APA

Smieszek, S., Przychodzen, B., Tyner, C., Johnson, C., Bushman, M., Brzezynski, J., Reich, A., Bachelez, H., Yap, E. W. Y., Borlu, M., Chaowattanapanit, S., Denguezli, M., Gudjonsson, J. E., Lizzul, P., Dahl, M., Parmley, S., Randazzo, B., Severtson, A., Raina, P., …, & Polymeropoulos, M. (2026). Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis. NEJM Evidence. https://doi.org/10.1056/evidoa2500272

Vancouver

Smieszek S, Przychodzen B, Tyner C, Johnson C, Bushman M, Brzezynski J, et al. Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis. NEJM Evidence. 2026. doi:10.1056/evidoa2500272

BibTeX
@article{Smieszek2026,
  author = {Smieszek, Sandra and Przychodzen, Bartlomiej and Tyner, Christina and Johnson, Caroline and Bushman, Margaret and Brzezynski, Jennifer and Reich, Adam and Bachelez, Hervé and Yap, Evelyn Wen Yee and Borlu, Murat and Chaowattanapanit, Suteeraporn and Denguezli, Mohamed and Gudjonsson, Johann E and Lizzul, Paul and Dahl, Martin and Parmley, Stephen and Randazzo, Bruce and Severtson, Anne and Raina, Priya and Saikali, Khalil and Xiao, Changfu and Polymeropoulos, Christos and Birznieks, Gunther and Polymeropoulos, Mihael},
  title = {Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis},
  journal = {NEJM Evidence},
  year = {2026},
  doi = {10.1056/evidoa2500272}
}
Kostenlos starten →